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Abstract
Twenty-five amide alkaloids (1–25) from Piper boehmeriifolium and 10 synthetic amide alkaloid 
derivatives (39–48) were evaluated for antiproliferative activity against eight human tumor cell 
lines, including chemosensitive and multidrug-resistant (MDR) cell lines. The results suggested 
tumor type-selectivity. 1-[7-(3,4,5-Trimethoxyphenyl)heptanoyl]piperidine (46) exhibited the best 
inhibitory activity (IC50 = 4.94 µM) against the P-glycoprotein (P-gp)-overexpressing KBvin 
MDR sub-line, while it and all other tested compounds, except 9, were inactive (IC50 >40 µM) 
against MDA-MB-231 and SK-BR-3. Structure-activity relationships (SARs) indicated that (i) 
3,4,5-trimethoxy phenyl substitution is critical for selectivity against KBvin, (ii) the 4-methoxy 
group in this pattern is crucial for antiproliferative activity, (iii) double bonds in the side chain are 
not needed for activity, and (iv), in arylalkenylacyl amide alkaloids, replacement of an 
isobutylamino group with pyrrolidin-1-yl or piperidin-1-yl significantly improved activity. Further 
study on Piper amides is warranted, particularly whether side chain length affects the ability to 
overcome the MDR cancer phenotype.
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The genus Piper (Piperaceae) contains approximately 2000 plant species distributed mainly 
in tropical areas.1 Among them, 10 Piper species have been used in traditional medicines to 
treat cancer or cancer-like symptoms.2 Amide alkaloids, phenylpropanoids, lignans, 
neolignans, terpenes, steroids, kawapyrones, piperolides, flavonoids, and alkenylphenols 
have been isolated from Piper plants,3–7 and amide alkaloids are the major cytotoxic 
constituents.2 Especially, piplartine (piperlongumine, Figure 1) exhibits the most promise 
showing broad-spectrum cytotoxicity against cancer cell lines in vitro. Furthermore, it also 
demonstrated excellent anticancer activity in vivo.8,9 The amide alkaloids in Piper plants are 
usually constructed from acyl and amino moieties. The acyl moiety includes mainly 
alkylacyl, alkenylacyl, arylalkylacyl, and arylalkenylacyl groups. The amino moiety is 
generally either isobutylamine, pyrrolidine, piperidine, pyrrole, 5,6-dihydropyridin-2(1H)-
one, or arylethylamine. In our previous study, several amides (3–7, and 11, Figure 2) with 
cytotoxic activity against the human cervical carcinoma HeLa cell line were isolated from P. 
boehmeriifolium Wall. The active amides belong to the arylalkenylacylpyrrolidine 
classification and 1-[(9E)-10-(3,4-methylenedioxyphenyl)-9-decenoyl]pyrrolidine (7) 
exhibited the best inhibitory activity with an IC50 of 7.78 µM.10 However, the structure-
activity relationships (SARs) of these amides against cancer cells remain unclear. In the 
present study, 25 amide alkaloids (1–25, Figure 2) from P. boehmeriifolium and 10 synthetic 
amide alkaloid analogues (39–48) were evaluated for cytotoxicity against lung 
adenocarcinoma A549, nasopharyngeal carcinoma KB, P-glycoprotein (P-gp)-
overexpressing MDR KB (KBvin), androgen insensitive prostate cancer DU145, and four 
breast cancer cell lines, including triple-negative [ER−/PgR−/erbB2 (HER2)−] MDA-
MB-231, triple-positive ZR-75-1, double-positive expressing multidrug resistance-
associated protein (MRP) 1 MCF-7, and HER2-overexpressing SK-BR-3 cell lines. The 
SARs and selective antiproliferative activity against KBvin are discussed.
Natural amide alkaloids (1–25) were obtained from the whole plant of P. boehmeriaefolium 
in our recent study.10 From results of their cytotoxic evaluation (Table 1), both an 
arylalkenylacyl side chain and pyrrolidin-1-yl moiety were necessary for antiproliferative 
activity. To determine whether double bonds in the arylalkenylacyl side chain affected 
activity, ten new amide alkaloids (39–48) were synthesized (Scheme 1). 3,4,5-
Trimethoxybenzaldehyde (26) was selected as the starting material to synthesize promising 
amide piplartine analogues. Ethyl (E)-3-(3,4,5-trimethoxyphenyl)acrylate (27) was obtained 
from 26 by 2C-Wittig homologation with (carboethoxymethylene)triphenylphosphorane in 
benzene at reflux.11 The esters 27, 29, and 34 were reduced with diisobutylaluminum 
hydride to afford alcohols 28, 30, and 35, respectively,12–13 while alcohol 33 was obtained 
by reduction of acid 32 using lithium aluminium hydride.14 Acid 32 was produced by 
hydrolysis of ester 27 with lithium hydroxide in a terahydrofuran (THF) and water (2:1) 
mixture.15 The alcohols 28, 30, 33, 35, and 37 were oxidized using the Parikh-Doering 
reaction with sulfur trioxide pyridine complex, dimethyl sulphoxide, and triethylamine and 
then subjected to Wittig reaction to yield esters 29, 31, 34, 36, and 38, respectively.16 Esters 
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31, 36, and 38 were hydrolyzed with lithium hydroxide in THF:water (2:1) to yield the 
corresponding acids. Reaction of these acids with pyrrolidine and thionyl chloride gave 
amides 39, 41, and 43, and with piperidine gave amides 40, 42, and 44, respectively.17 
Hydrogenation of 35, 41, and 44 with hydrogen gas at 50 psi yielded 37, 45 and 46, 
respectively,18 and selective de-4'-O-methylation of 43 and 44 using aluminium trichloride 
gave 47 and 48, respectively.9
The cytotoxic activity was determined by the sulforhodamine B (SRB) colorimetric assay as 
previously described.19 As shown in Table 1, the natural (1–3, and 7–10) and synthetic (43–
46) alkaloids showed cytotoxic activity against at least one of the eight human tumor cell 
lines (Table 1). Within the natural products (1–25), compounds 3 and 7–10 exhibited weak 
and broad spectrum activity against all tumor cell lines tested except MDA-MB-231 and 
SK-BR3. Compounds 1 and 2 were inactive (IC50 > 40 µM) against four types of breast 
cancer cell lines. Interestingly, none of the compounds except 9 were active against MDA-
MB-231 and SK-BR-3, suggesting tumor type-selective antiproliferative activity. Compared 
with the natural products, the synthetic amides 43–46 showed better cytotoxic activity 
against KBvin cells. 1-[7-(3,4,5-Trimethoxyphenyl)heptanoyl]piperidine (46) was the most 
active analog against KBvin cells (IC50 = 4.94 µM). P-glycoprotein (P-gp)-overexpressing 
KBvin was sensitive to the synthetic analogs (43–46), while chemosensitive cell lines, 
including parental cell line KB, were tolerant. Compound 44 showed the best selective index 
(3.8-fold selective) against MDR sub-line KBvin compared with parental KB. It is obvious 
that the 3,4,5-trimethoxy groups in the phenyl ring of the synthetic compounds increase the 
selectivity. Multidrug resistance-associated protein 1 (MRP1)-expressing MCF-7 was also 
tolerant to amides 43–46, suggesting that these analogs may be selectively cytotoxic to 
MDR cells overexpressing P-gp.
Double bonds in the side chain might decrease the cytotoxic activity, because compounds 
39–42 were inactive against the tested cell lines. Compounds 47 and 48 were inactive, 
implying that a 4-methoxy group, rather than 4-hydroxy group, in the 3,4,5-trisubstituted 
phenyl ring is necessary for activity. Compared with amides 1 and 2, amides 12 and 13 were 
inactive indicating that pyrrolidin-1-yl derivatives are more potent than isobutylamino 
derivatives, while both pyrrolidin-1-yl (43 and 45) and piperidin-1-yl (44 and 46) groups are 
acceptable for activity.
In conclusion, arylalkenylacylpyrrolidines (1–3, 7–10, 43), an arylalkylacylpyrrolidine (45), 
an arylalkenylacylpiperidine (44), and an arylalkylacylpiperidine (46) showed inhibitory 
activity against at least one of eight tested human tumor cell lines. Double bonds in the side 
chain were not needed for activity. 3,4,5-Trimethoxy substitution in the phenyl ring of the 
amide alkaloids increased selectivity against MDR sub-line KBvin, while the 4-methoxy 
group in this pattern is required for cytotoxic activity. These results demonstrate that newly 
synthesized amide alkaloids show tumor type-selective antiproliferative activity, especially 
against MDR cells. These synthesized analogues may target a unique protein that is highly 
responsible for the proliferation of KBvin, while dispensable in chemosensitive cell lines, 
such as SK-BR-3 and MDA-MD-231. Compounds, such as verapamil and desmosdumotin B 
analogues,19 that show at least a two-fold selective cytotoxicity against MDR cells are called 
collateral sensitivity (CS) agents.20 Although their mechanisms of action are largely unclear, 
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CS agents are expected to be a new class of chemopreventive adjuvant for cancer 
chemotherapy to suppress development of MDR phenotype.21 Thus, it is worthwhile to 
conduct further SAR study of Piper amides, including the effect of the side chain length on 
the activity of these amide alkaloids against cancer cells showing the MDR phenotype.
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The structure of piplartine (piperlongumine).
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The structures of amide alkaloids (1–25) from Piper boehmeriaefolium.
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Synthesis of amide alkaloids (39–48). Reagents and conditions: (a) Ph3P=CHCO2Et, 
benzene, refluxed, 4 h; (b) DIBAL-H (1.0 M in THF), CH2Cl2, −50 °C to rt, 2 h; (c) (i) 
Py·SO3, DMSO, Et3N, CH2Cl2, 0 °C to rt, 2 h; (ii) Ph3P=CHCO2Et, benzene, refluxed, 4 h; 
(d) (i) LiOH·H2O, THF-H2O (2:1), rt, 36 h; (ii) SOCl2, CH2Cl2, refluxed, 1 h; (iii) 
pyrrolidine (for 39, 41, and 43) or piperidine (for 40, 42, and 44), CH2Cl2, rt, 30 min; (e) 
LiOH·H2O, THF-H2O (2:1), rt, 36 h; (f) LiAlH4, THF, 0 °C to rt, overnight; (g) 10% Pd/C, 
EtOAc, H2, 50 psi, 24 h; (h) AlCl3, CH2Cl2, rt, 4 h.
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